Global Coronary Stents

Coronary Stents Comprehensive Study by Type (Drug-Eluting Stents, Bioabsorbable Stents, Bare Metal Stents), Application (Ambulatory Surgical Centers, Hospitals, Cardiac Centers), Material (Metallic, Polymeric, Natural), Mode Of Delivery (Self-Expanding Stents, Balloon-Expandable Stents) Players and Region - United States Market Outlook to 2027

Coronary Stents Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 8.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
A coronary stent is referred to as a miniature tube which is been used to open a narrowed artery during the procedure of PCI (percutaneous coronary intervention). This kind of treatment comprises of the insertion of a balloon-tipped tube in the artery system which is then transported to the location of the blockage. The stent enlarges and after the balloon inflates it forms a platform. This procedure helps the artery to open and stabilize the flow of blood to the heart. The Coronary stents are basically used in the treatment of cardiac disorders like myocardial infarction, angina pain, and coronary artery disease. The market of the coronary stents is increasing due to the growing demand for procedures of minimally invasive surgical. While some of the factors like the risk associated with the surgery and technical issue regarding the stents can cause the hampering of the market.The research analyst at AMA estimates Coronary Stents market to grow at a compounded annual growth rate of 8.8%

Segment Analysis
AMA Research have segmented the market of United States Coronary Stents market by Type, Application and Region. On the basis of Type, Drug-Eluting Stents are dominating the market in the year 2021

On the basis of geography, the market of Coronary Stents has been segmented into North America (United States, Canada, Mexico).

Market Trend
Growing patient pool coupled with introduction of cutting-edge equipment

Market Drivers
Technological Advancements in the Coronary Stents and High Demand for Minimally Invasive Surgical Procedures

Opportunities
Declining Prices Of Coronary Stents and Advantages like Reduced Hospital Stays, and Lesser Healing Time Associated with Use of Advanced and Miniaturized Coronary Stents.

Restraints
  • Technical Issues in CT Imaging of Coronary Stents


In addition to the aforementioned factor, Technological Advancements in the Coronary Stents is expected to propel the growth of the market over the forecast period.

Competitive Landscape
The market is fragmented by key vendors who are focusing on production technologies, improving efficiency and shelf life. Growth opportunities can be captured by tracking the ongoing process improvement and financial flexibility to invest in optimal strategies
The key Players profiled in the study are Abbott Laboratories (United States), Boston Scientific Corporation (United States), Elixir Medical Corporation (United States), Reva Medical Inc. (United States), C. R. Bard, Inc. (United States), Medtronic (United States), Proven Process Medical Devices, Inc. (United States), Edwards Lifesciences (United States) and W. L. Gore & Associates (United States). A lot of United States players are profiled in the research study indicating a strong market dependence.

Report Objectives / Segmentation Covered

By Type
  • Drug-Eluting Stents
  • Bioabsorbable Stents
  • Bare Metal Stents
By Application
  • Ambulatory Surgical Centers
  • Hospitals
  • Cardiac Centers
By Material
  • Metallic
  • Polymeric
  • Natural

By Mode Of Delivery
  • Self-Expanding Stents
  • Balloon-Expandable Stents

By Regions
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Technological Advancements in the Coronary Stents
      • 3.2.2. High Demand for Minimally Invasive Surgical Procedures
    • 3.3. Market Challenges
      • 3.3.1. Risks Associated with the Operation
    • 3.4. Market Trends
      • 3.4.1. Growing patient pool coupled with introduction of cutting-edge equipment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. United States Coronary Stents, by Type, Application, Material, Mode Of Delivery and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. United States Coronary Stents (Value)
      • 5.2.1. United States Coronary Stents by: Type (Value)
        • 5.2.1.1. Drug-Eluting Stents
        • 5.2.1.2. Bioabsorbable Stents
        • 5.2.1.3. Bare Metal Stents
      • 5.2.2. United States Coronary Stents by: Application (Value)
        • 5.2.2.1. Ambulatory Surgical Centers
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Cardiac Centers
      • 5.2.3. United States Coronary Stents by: Material (Value)
        • 5.2.3.1. Metallic
        • 5.2.3.2. Polymeric
        • 5.2.3.3. Natural
      • 5.2.4. United States Coronary Stents by: Mode Of Delivery (Value)
        • 5.2.4.1. Self-Expanding Stents
        • 5.2.4.2. Balloon-Expandable Stents
      • 5.2.5. United States Coronary Stents Region
        • 5.2.5.1. North America
          • 5.2.5.1.1. United States
          • 5.2.5.1.2. Canada
          • 5.2.5.1.3. Mexico
    • 5.3. United States Coronary Stents (Volume)
      • 5.3.1. United States Coronary Stents by: Type (Volume)
        • 5.3.1.1. Drug-Eluting Stents
        • 5.3.1.2. Bioabsorbable Stents
        • 5.3.1.3. Bare Metal Stents
      • 5.3.2. United States Coronary Stents by: Application (Volume)
        • 5.3.2.1. Ambulatory Surgical Centers
        • 5.3.2.2. Hospitals
        • 5.3.2.3. Cardiac Centers
      • 5.3.3. United States Coronary Stents by: Material (Volume)
        • 5.3.3.1. Metallic
        • 5.3.3.2. Polymeric
        • 5.3.3.3. Natural
      • 5.3.4. United States Coronary Stents by: Mode Of Delivery (Volume)
        • 5.3.4.1. Self-Expanding Stents
        • 5.3.4.2. Balloon-Expandable Stents
      • 5.3.5. United States Coronary Stents Region
        • 5.3.5.1. North America
          • 5.3.5.1.1. United States
          • 5.3.5.1.2. Canada
          • 5.3.5.1.3. Mexico
    • 5.4. United States Coronary Stents (Price)
      • 5.4.1. United States Coronary Stents by: Type (Price)
  • 6. Coronary Stents: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elixir Medical Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Reva Medical Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. C. R. Bard, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Proven Process Medical Devices, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Edwards Lifesciences (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. W. L. Gore & Associates (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. United States Coronary Stents Sale, by Type, Application, Material, Mode Of Delivery and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. United States Coronary Stents (Value)
      • 7.2.1. United States Coronary Stents by: Type (Value)
        • 7.2.1.1. Drug-Eluting Stents
        • 7.2.1.2. Bioabsorbable Stents
        • 7.2.1.3. Bare Metal Stents
      • 7.2.2. United States Coronary Stents by: Application (Value)
        • 7.2.2.1. Ambulatory Surgical Centers
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Cardiac Centers
      • 7.2.3. United States Coronary Stents by: Material (Value)
        • 7.2.3.1. Metallic
        • 7.2.3.2. Polymeric
        • 7.2.3.3. Natural
      • 7.2.4. United States Coronary Stents by: Mode Of Delivery (Value)
        • 7.2.4.1. Self-Expanding Stents
        • 7.2.4.2. Balloon-Expandable Stents
      • 7.2.5. United States Coronary Stents Region
        • 7.2.5.1. North America
          • 7.2.5.1.1. United States
          • 7.2.5.1.2. Canada
          • 7.2.5.1.3. Mexico
    • 7.3. United States Coronary Stents (Volume)
      • 7.3.1. United States Coronary Stents by: Type (Volume)
        • 7.3.1.1. Drug-Eluting Stents
        • 7.3.1.2. Bioabsorbable Stents
        • 7.3.1.3. Bare Metal Stents
      • 7.3.2. United States Coronary Stents by: Application (Volume)
        • 7.3.2.1. Ambulatory Surgical Centers
        • 7.3.2.2. Hospitals
        • 7.3.2.3. Cardiac Centers
      • 7.3.3. United States Coronary Stents by: Material (Volume)
        • 7.3.3.1. Metallic
        • 7.3.3.2. Polymeric
        • 7.3.3.3. Natural
      • 7.3.4. United States Coronary Stents by: Mode Of Delivery (Volume)
        • 7.3.4.1. Self-Expanding Stents
        • 7.3.4.2. Balloon-Expandable Stents
      • 7.3.5. United States Coronary Stents Region
        • 7.3.5.1. North America
          • 7.3.5.1.1. United States
          • 7.3.5.1.2. Canada
          • 7.3.5.1.3. Mexico
    • 7.4. United States Coronary Stents (Price)
      • 7.4.1. United States Coronary Stents by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Coronary Stents: by Type(USD Million)
  • Table 2. Coronary Stents Drug-Eluting Stents , by Region USD Million (2016-2021)
  • Table 3. Coronary Stents Bioabsorbable Stents , by Region USD Million (2016-2021)
  • Table 4. Coronary Stents Bare Metal Stents , by Region USD Million (2016-2021)
  • Table 5. Coronary Stents: by Application(USD Million)
  • Table 6. Coronary Stents Ambulatory Surgical Centers , by Region USD Million (2016-2021)
  • Table 7. Coronary Stents Hospitals , by Region USD Million (2016-2021)
  • Table 8. Coronary Stents Cardiac Centers , by Region USD Million (2016-2021)
  • Table 9. Coronary Stents: by Material(USD Million)
  • Table 10. Coronary Stents Metallic , by Region USD Million (2016-2021)
  • Table 11. Coronary Stents Polymeric , by Region USD Million (2016-2021)
  • Table 12. Coronary Stents Natural , by Region USD Million (2016-2021)
  • Table 13. Coronary Stents: by Mode Of Delivery(USD Million)
  • Table 14. Coronary Stents Self-Expanding Stents , by Region USD Million (2016-2021)
  • Table 15. Coronary Stents Balloon-Expandable Stents , by Region USD Million (2016-2021)
  • Table 16. North America Coronary Stents, by Country USD Million (2016-2021)
  • Table 17. North America Coronary Stents, by Type USD Million (2016-2021)
  • Table 18. North America Coronary Stents, by Application USD Million (2016-2021)
  • Table 19. North America Coronary Stents, by Material USD Million (2016-2021)
  • Table 20. North America Coronary Stents, by Mode Of Delivery USD Million (2016-2021)
  • Table 21. United States Coronary Stents, by Type USD Million (2016-2021)
  • Table 22. United States Coronary Stents, by Application USD Million (2016-2021)
  • Table 23. United States Coronary Stents, by Material USD Million (2016-2021)
  • Table 24. United States Coronary Stents, by Mode Of Delivery USD Million (2016-2021)
  • Table 25. Canada Coronary Stents, by Type USD Million (2016-2021)
  • Table 26. Canada Coronary Stents, by Application USD Million (2016-2021)
  • Table 27. Canada Coronary Stents, by Material USD Million (2016-2021)
  • Table 28. Canada Coronary Stents, by Mode Of Delivery USD Million (2016-2021)
  • Table 29. Mexico Coronary Stents, by Type USD Million (2016-2021)
  • Table 30. Mexico Coronary Stents, by Application USD Million (2016-2021)
  • Table 31. Mexico Coronary Stents, by Material USD Million (2016-2021)
  • Table 32. Mexico Coronary Stents, by Mode Of Delivery USD Million (2016-2021)
  • Table 33. Coronary Stents Sales: by Type(Units)
  • Table 34. Coronary Stents Sales Drug-Eluting Stents , by Region Units (2016-2021)
  • Table 35. Coronary Stents Sales Bioabsorbable Stents , by Region Units (2016-2021)
  • Table 36. Coronary Stents Sales Bare Metal Stents , by Region Units (2016-2021)
  • Table 37. Coronary Stents Sales: by Application(Units)
  • Table 38. Coronary Stents Sales Ambulatory Surgical Centers , by Region Units (2016-2021)
  • Table 39. Coronary Stents Sales Hospitals , by Region Units (2016-2021)
  • Table 40. Coronary Stents Sales Cardiac Centers , by Region Units (2016-2021)
  • Table 41. Coronary Stents Sales: by Material(Units)
  • Table 42. Coronary Stents Sales Metallic , by Region Units (2016-2021)
  • Table 43. Coronary Stents Sales Polymeric , by Region Units (2016-2021)
  • Table 44. Coronary Stents Sales Natural , by Region Units (2016-2021)
  • Table 45. Coronary Stents Sales: by Mode Of Delivery(Units)
  • Table 46. Coronary Stents Sales Self-Expanding Stents , by Region Units (2016-2021)
  • Table 47. Coronary Stents Sales Balloon-Expandable Stents , by Region Units (2016-2021)
  • Table 48. North America Coronary Stents Sales, by Country Units (2016-2021)
  • Table 49. North America Coronary Stents Sales, by Type Units (2016-2021)
  • Table 50. North America Coronary Stents Sales, by Application Units (2016-2021)
  • Table 51. North America Coronary Stents Sales, by Material Units (2016-2021)
  • Table 52. North America Coronary Stents Sales, by Mode Of Delivery Units (2016-2021)
  • Table 53. United States Coronary Stents Sales, by Type Units (2016-2021)
  • Table 54. United States Coronary Stents Sales, by Application Units (2016-2021)
  • Table 55. United States Coronary Stents Sales, by Material Units (2016-2021)
  • Table 56. United States Coronary Stents Sales, by Mode Of Delivery Units (2016-2021)
  • Table 57. Canada Coronary Stents Sales, by Type Units (2016-2021)
  • Table 58. Canada Coronary Stents Sales, by Application Units (2016-2021)
  • Table 59. Canada Coronary Stents Sales, by Material Units (2016-2021)
  • Table 60. Canada Coronary Stents Sales, by Mode Of Delivery Units (2016-2021)
  • Table 61. Mexico Coronary Stents Sales, by Type Units (2016-2021)
  • Table 62. Mexico Coronary Stents Sales, by Application Units (2016-2021)
  • Table 63. Mexico Coronary Stents Sales, by Material Units (2016-2021)
  • Table 64. Mexico Coronary Stents Sales, by Mode Of Delivery Units (2016-2021)
  • Table 65. Coronary Stents: by Type(USD/Units)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Coronary Stents: by Type(USD Million)
  • Table 76. Coronary Stents Drug-Eluting Stents , by Region USD Million (2022-2027)
  • Table 77. Coronary Stents Bioabsorbable Stents , by Region USD Million (2022-2027)
  • Table 78. Coronary Stents Bare Metal Stents , by Region USD Million (2022-2027)
  • Table 79. Coronary Stents: by Application(USD Million)
  • Table 80. Coronary Stents Ambulatory Surgical Centers , by Region USD Million (2022-2027)
  • Table 81. Coronary Stents Hospitals , by Region USD Million (2022-2027)
  • Table 82. Coronary Stents Cardiac Centers , by Region USD Million (2022-2027)
  • Table 83. Coronary Stents: by Material(USD Million)
  • Table 84. Coronary Stents Metallic , by Region USD Million (2022-2027)
  • Table 85. Coronary Stents Polymeric , by Region USD Million (2022-2027)
  • Table 86. Coronary Stents Natural , by Region USD Million (2022-2027)
  • Table 87. Coronary Stents: by Mode Of Delivery(USD Million)
  • Table 88. Coronary Stents Self-Expanding Stents , by Region USD Million (2022-2027)
  • Table 89. Coronary Stents Balloon-Expandable Stents , by Region USD Million (2022-2027)
  • Table 90. North America Coronary Stents, by Country USD Million (2022-2027)
  • Table 91. North America Coronary Stents, by Type USD Million (2022-2027)
  • Table 92. North America Coronary Stents, by Application USD Million (2022-2027)
  • Table 93. North America Coronary Stents, by Material USD Million (2022-2027)
  • Table 94. North America Coronary Stents, by Mode Of Delivery USD Million (2022-2027)
  • Table 95. United States Coronary Stents, by Type USD Million (2022-2027)
  • Table 96. United States Coronary Stents, by Application USD Million (2022-2027)
  • Table 97. United States Coronary Stents, by Material USD Million (2022-2027)
  • Table 98. United States Coronary Stents, by Mode Of Delivery USD Million (2022-2027)
  • Table 99. Canada Coronary Stents, by Type USD Million (2022-2027)
  • Table 100. Canada Coronary Stents, by Application USD Million (2022-2027)
  • Table 101. Canada Coronary Stents, by Material USD Million (2022-2027)
  • Table 102. Canada Coronary Stents, by Mode Of Delivery USD Million (2022-2027)
  • Table 103. Mexico Coronary Stents, by Type USD Million (2022-2027)
  • Table 104. Mexico Coronary Stents, by Application USD Million (2022-2027)
  • Table 105. Mexico Coronary Stents, by Material USD Million (2022-2027)
  • Table 106. Mexico Coronary Stents, by Mode Of Delivery USD Million (2022-2027)
  • Table 107. Coronary Stents Sales: by Type(Units)
  • Table 108. Coronary Stents Sales Drug-Eluting Stents , by Region Units (2022-2027)
  • Table 109. Coronary Stents Sales Bioabsorbable Stents , by Region Units (2022-2027)
  • Table 110. Coronary Stents Sales Bare Metal Stents , by Region Units (2022-2027)
  • Table 111. Coronary Stents Sales: by Application(Units)
  • Table 112. Coronary Stents Sales Ambulatory Surgical Centers , by Region Units (2022-2027)
  • Table 113. Coronary Stents Sales Hospitals , by Region Units (2022-2027)
  • Table 114. Coronary Stents Sales Cardiac Centers , by Region Units (2022-2027)
  • Table 115. Coronary Stents Sales: by Material(Units)
  • Table 116. Coronary Stents Sales Metallic , by Region Units (2022-2027)
  • Table 117. Coronary Stents Sales Polymeric , by Region Units (2022-2027)
  • Table 118. Coronary Stents Sales Natural , by Region Units (2022-2027)
  • Table 119. Coronary Stents Sales: by Mode Of Delivery(Units)
  • Table 120. Coronary Stents Sales Self-Expanding Stents , by Region Units (2022-2027)
  • Table 121. Coronary Stents Sales Balloon-Expandable Stents , by Region Units (2022-2027)
  • Table 122. North America Coronary Stents Sales, by Country Units (2022-2027)
  • Table 123. North America Coronary Stents Sales, by Type Units (2022-2027)
  • Table 124. North America Coronary Stents Sales, by Application Units (2022-2027)
  • Table 125. North America Coronary Stents Sales, by Material Units (2022-2027)
  • Table 126. North America Coronary Stents Sales, by Mode Of Delivery Units (2022-2027)
  • Table 127. United States Coronary Stents Sales, by Type Units (2022-2027)
  • Table 128. United States Coronary Stents Sales, by Application Units (2022-2027)
  • Table 129. United States Coronary Stents Sales, by Material Units (2022-2027)
  • Table 130. United States Coronary Stents Sales, by Mode Of Delivery Units (2022-2027)
  • Table 131. Canada Coronary Stents Sales, by Type Units (2022-2027)
  • Table 132. Canada Coronary Stents Sales, by Application Units (2022-2027)
  • Table 133. Canada Coronary Stents Sales, by Material Units (2022-2027)
  • Table 134. Canada Coronary Stents Sales, by Mode Of Delivery Units (2022-2027)
  • Table 135. Mexico Coronary Stents Sales, by Type Units (2022-2027)
  • Table 136. Mexico Coronary Stents Sales, by Application Units (2022-2027)
  • Table 137. Mexico Coronary Stents Sales, by Material Units (2022-2027)
  • Table 138. Mexico Coronary Stents Sales, by Mode Of Delivery Units (2022-2027)
  • Table 139. Coronary Stents: by Type(USD/Units)
  • Table 140. Research Programs/Design for This Report
  • Table 141. Key Data Information from Secondary Sources
  • Table 142. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. United States Coronary Stents: by Type USD Million (2016-2021)
  • Figure 5. United States Coronary Stents: by Application USD Million (2016-2021)
  • Figure 6. United States Coronary Stents: by Material USD Million (2016-2021)
  • Figure 7. United States Coronary Stents: by Mode Of Delivery USD Million (2016-2021)
  • Figure 8. North America Coronary Stents Share (%), by Country
  • Figure 9. United States Coronary Stents: by Type Units (2016-2021)
  • Figure 10. United States Coronary Stents: by Application Units (2016-2021)
  • Figure 11. United States Coronary Stents: by Material Units (2016-2021)
  • Figure 12. United States Coronary Stents: by Mode Of Delivery Units (2016-2021)
  • Figure 13. North America Coronary Stents Share (%), by Country
  • Figure 14. United States Coronary Stents: by Type USD/Units (2016-2021)
  • Figure 15. United States Coronary Stents share by Players 2021 (%)
  • Figure 16. United States Coronary Stents share by Players (Top 3) 2021(%)
  • Figure 17. United States Coronary Stents share by Players (Top 5) 2021(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 20. Abbott Laboratories (United States) Revenue: by Geography 2021
  • Figure 21. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Boston Scientific Corporation (United States) Revenue: by Geography 2021
  • Figure 23. Elixir Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Elixir Medical Corporation (United States) Revenue: by Geography 2021
  • Figure 25. Reva Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Reva Medical Inc. (United States) Revenue: by Geography 2021
  • Figure 27. C. R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. C. R. Bard, Inc. (United States) Revenue: by Geography 2021
  • Figure 29. Medtronic (United States) Revenue, Net Income and Gross profit
  • Figure 30. Medtronic (United States) Revenue: by Geography 2021
  • Figure 31. Proven Process Medical Devices, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Proven Process Medical Devices, Inc. (United States) Revenue: by Geography 2021
  • Figure 33. Edwards Lifesciences (United States) Revenue, Net Income and Gross profit
  • Figure 34. Edwards Lifesciences (United States) Revenue: by Geography 2021
  • Figure 35. W. L. Gore & Associates (United States) Revenue, Net Income and Gross profit
  • Figure 36. W. L. Gore & Associates (United States) Revenue: by Geography 2021
  • Figure 37. United States Coronary Stents: by Type USD Million (2022-2027)
  • Figure 38. United States Coronary Stents: by Application USD Million (2022-2027)
  • Figure 39. United States Coronary Stents: by Material USD Million (2022-2027)
  • Figure 40. United States Coronary Stents: by Mode Of Delivery USD Million (2022-2027)
  • Figure 41. North America Coronary Stents Share (%), by Country
  • Figure 42. United States Coronary Stents: by Type Units (2022-2027)
  • Figure 43. United States Coronary Stents: by Application Units (2022-2027)
  • Figure 44. United States Coronary Stents: by Material Units (2022-2027)
  • Figure 45. United States Coronary Stents: by Mode Of Delivery Units (2022-2027)
  • Figure 46. North America Coronary Stents Share (%), by Country
  • Figure 47. United States Coronary Stents: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Boston Scientific Corporation (United States)
  • Elixir Medical Corporation (United States)
  • Reva Medical Inc. (United States)
  • C. R. Bard, Inc. (United States)
  • Medtronic (United States)
  • Proven Process Medical Devices, Inc. (United States)
  • Edwards Lifesciences (United States)
  • W. L. Gore & Associates (United States)
Select User Access Type

Key Highlights of Report


Feb 2022 207 Pages 89 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Coronary Stents Quantitative research analysis
Global Coronary Stents Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Coronary Stents market is expected to see a CAGR of 8.8% during projected year 2021 to 2027.
Top performing companies in the United States Coronary Stents market are Abbott Laboratories (United States), Boston Scientific Corporation (United States), Elixir Medical Corporation (United States), Reva Medical Inc. (United States), C. R. Bard, Inc. (United States), Medtronic (United States), Proven Process Medical Devices, Inc. (United States), Edwards Lifesciences (United States) and W. L. Gore & Associates (United States), to name a few.
Drug-Eluting Stents is dominating segment of Coronary Stents Market in 2021.

Know More About Global Coronary Stents Report?

Have a Query? Click Here

Other Related Reports

Duodenal Stent Comprehensive Study by Type (Metal Duodenal Stent, Polymer Duodenal Stent), Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Other Applicati...
$ 3450
Medical Imaging Phantoms Comprehensive Study by Type (X-ray/Fluoroscopy Phantoms, Ultrasound Phantoms, CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, Others), Application (Hospitals, Academic &...
$ 3650
Ureteral Access Sheath Comprehensive Study by Application (Hospitals, Clinics), Diameter (Fr < 10, 10<= Fr <13, 13<= Fr <=15) Players and Region - Global Market Outlook to 2024
$ 3500
Cosmetic Lasers Comprehensive Study by Type (Ablative Laser, Non-Ablative Laser), Application (Fine Lines and Wrinkles, Skin Tightening, Pigmented Lesions, Precancerous Lesions, Vascular Lesions, Tat...
$ 3650
Surgical Drapes Comprehensive Study by Type (Incise, Laparoscopy, Laparotomy, Leggings, Lithotomy, Sheets, Others), Application (Surgical Treatment, Sterilization, Others), By End User (Hospitals, Cl...
$ 3750
Blood Gas and Electrolyte Analyzers Comprehensive Study by Type (Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers), End Use (Hospitals, Clinics, Ambulatory Surgical Centers (ASC), Other...
$ 3450